Published in N Engl J Med on February 24, 1966
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum (1990) 8.67
The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum (1990) 8.36
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum (1990) 8.23
The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med (1998) 7.18
Effects of affirmative action in medical schools. A study of the class of 1975. N Engl J Med (1985) 6.29
Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature (1990) 5.86
The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum (1990) 5.09
Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature (1990) 4.87
The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum (1990) 4.43
The human costs of tobacco use (1) N Engl J Med (1994) 3.24
The macrophage receptor for IgG: number and affinity of binding sites. J Immunol (1973) 2.91
Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest (2001) 2.84
The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.82
Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med (1985) 2.82
Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes (1974) 2.77
Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J Clin Invest (1997) 2.56
Renal abnormalities in rheumatoid arthritis. Ann Rheum Dis (1968) 2.42
Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care (2000) 2.36
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum (1990) 2.32
Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J Immunol (1985) 2.31
Patient-physician covenant. JAMA (1995) 2.29
In vitro adherence of soluble immune complexes to macrophages. J Exp Med (1972) 2.26
Osmotic and nonosmotic control of vasopressin release. Am J Physiol (1979) 2.18
Urinary diagnostic indices in acute renal failure: a prospective study. Ann Intern Med (1978) 2.13
A methicillin-resistant strain of Staphylococcus aureus. Clinical and laboratory experience. Ann Intern Med (1967) 2.11
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum (1990) 2.02
We're at war--but where are our troops? Hosp Pract (Off Ed) (1994) 2.01
The human costs of tobacco use (2) N Engl J Med (1994) 1.93
Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis (2000) 1.86
Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney. J Clin Invest (1975) 1.85
Studies on antigen-antibody complexes. II. Quantification of tissue uptake of soluble complexes in normal and complement-depleted rabbits. J Immunol (1971) 1.77
Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med (1987) 1.76
The preservation of life. JAMA (1970) 1.76
The clinical significance of Aeromonas hydrophila. Report of two cases. Arch Intern Med (1966) 1.72
Mechanism of the antidiuretic effect associated with interruption of parasympathetic pathways. J Clin Invest (1972) 1.72
Educating medical students. Assessing change in medical education--the road to implementation. Acad Med (1993) 1.71
Effects of hematocrit on renal hemodynamics and sodium excretion in hydropenic and volume-expanded dogs. J Clin Invest (1970) 1.67
In-vitro activity of cephalothin/kanamycin and methicillin/kanamycin combinations against methicillin-resistant Staphylococcus aureus. Lancet (1967) 1.65
Nonoliguric acute renal failure. N Engl J Med (1977) 1.64
Molecular composition and sedimentation characteristics of soluble antigen-antibody complexes. Biochemistry (1972) 1.64
Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int (1998) 1.64
Unrecognized adult salicylate intoxication. Ann Intern Med (1976) 1.63
Views on euthanasia. J Med Educ (1971) 1.62
Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1994) 1.61
Decreased incidence of antibiotic resistance among Staphylococcus aureus. A study in a university hospital over a 9-year period. Ann Intern Med (1968) 1.60
Mechanism of antidiuretic effect of beta adrenergic stimulation. J Clin Invest (1972) 1.54
Role of vasopressin in the impaired water excretion of glucocorticoid deficiency. Kidney Int (1980) 1.50
Postoperative hyponatremia. A prospective study. Arch Intern Med (1986) 1.50
Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med (1981) 1.49
Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med (1982) 1.48
The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum (1990) 1.46
The effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a pooled analysis of individual-patient data from 11 randomized, controlled trials. Ann Intern Med (2001) 1.44
Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease. Ann Intern Med (1991) 1.44
Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody. Arthritis Rheum (2004) 1.43
Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int (2001) 1.41
Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care (1996) 1.40
Infusion of glycine does not attenuate in vivo ischemic acute renal failure in the rat. J Lab Clin Med (1993) 1.40
Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med (1988) 1.40
Health care reform at $2 a pack. Hosp Pract (Off Ed) (1993) 1.39
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum (1990) 1.38
Nutrition education. Acad Med (1989) 1.38
Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1997) 1.37
Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med (1998) 1.36
Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int (1990) 1.36
Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am J Kidney Dis (1998) 1.32
In vitro effectiveness of kanamycin and kanamycin/cephalothin against Klebsiella. Comparison with other antibiotics. Ann Intern Med (1967) 1.32
Renal tubular acidosis associated with toluene "sniffing". N Engl J Med (1974) 1.32
The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils. Lymphokine Cytokine Res (1994) 1.30
Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects. J Am Soc Nephrol (2001) 1.29
Polyuria of thyrotoxicosis: downregulation of aquaporin water channels and increased solute excretion. Kidney Int (2007) 1.28
Mechanism of effect of alpha adrenergic stimulation with norepinephrine on renal water excretion. J Clin Invest (1973) 1.28
Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology (1998) 1.27
Diagnosis of Torulopsis glabrata infection. Successful treatment of two cases. JAMA (1968) 1.27
Reversible abnormalities in phagocytic function in poorly controlled diabetic patients. Am J Med Sci (1972) 1.27
Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol (1997) 1.26
Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum (1994) 1.26
Medical professional liability and the delivery of obstetrical care. N Engl J Med (1989) 1.26
Upregulation of aquaporin-2 water channel expression in chronic heart failure rat. J Clin Invest (1997) 1.25
Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann Intern Med (1982) 1.24
In vivo effect of indomethacin to potentiate the renal medullary cyclic AMP response to vasopressin. J Clin Invest (1977) 1.24
The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int (1989) 1.24
Effect of different media on in vitro studies of antibiotic combinations. Appl Microbiol (1968) 1.24
Loop diuretic infusion increases thiazide-sensitive Na(+)/Cl(-)-cotransporter abundance: role of aldosterone. J Am Soc Nephrol (2001) 1.23
Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci U S A (1994) 1.20
Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion. Am J Physiol Renal Physiol (2000) 1.18
Clinical differentiation between giant cell (temporal) arteritis and Takayasu's arteritis. J Rheumatol (1996) 1.18
Neutral protease secretion by human monocytes. Effect of surface-bound immune complexes. J Exp Med (1979) 1.18
Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. Am J Respir Cell Mol Biol (1994) 1.18
Diagnostic importance of an increased serum anion gap. N Engl J Med (1980) 1.18
Characteristics of bacterial lipopolysaccharide induction of interleukin 1 synthesis and secretion by human monocytes. Clin Exp Immunol (1986) 1.18
Teaching family medicine in rural clinical clerkships. A WAMI progress report. JAMA (1974) 1.18
Renal, metabolic, and circulatory responses to heat and exercise. Studies in military recruits during summer training, with implications for acute renal failure. Ann Intern Med (1970) 1.18
Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail (1998) 1.17
The effect of complement in adherent immune complexes on Fc and C3 receptor expression in human monocytes. Immunology (1981) 1.17
Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure. Kidney Int (1986) 1.16
Effect of beta-adrenergic blockade and inhibitors of angiotensin II and prostaglandins on renal autoregulation. Am J Physiol (1975) 1.16
Loss of Fc receptor activity after culture of human monocytes on surface-bound immune complexes. Mediation by cyclic nucleotides. J Exp Med (1980) 1.16
Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J Clin Invest (1988) 1.15
Mechanism of suppression of vasopressin during alpha-adrenergic stimulation with norepinephrine. J Clin Invest (1974) 1.15
Community clinical clerkships for educating family medicine students. Process of development (a WAMI progress report). J Fam Pract (1975) 1.15